ApicHope Pharmaceutical Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,259.5 million compared to CNY 903.71 million a year ago. Revenue was CNY 1,265.71 million compared to CNY 905.11 million a year ago.

Net income was CNY 204.94 million compared to CNY 154.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.4656 compared to CNY 0.3513 a year ago. Diluted earnings per share from continuing operations was CNY 0.4656 compared to CNY 0.3513 a year ago.